Related Experiment Video
Updated: Jun 1, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
Implantable cardioverter defibrillator prevents sudden cardiac death in systemic sclerosis
Pasquale Bernardo1, Maria Letizia Conforti, Silvia Bellando-Randone
1Department of Critical Care Medicine and Surgery, University of Florence, Florence, Italy.
Insights
Implantable cardioverter-defibrillators (ICDs) can prevent sudden cardiac death in patients with systemic sclerosis (SSc) who experience ventricular arrhythmias. This study shows ICDs effectively managed dangerous heart rhythms in SSc patients.
Area of Science:
- Cardiology
- Rheumatology
- Medical Devices
Background:
- Cardiac involvement in systemic sclerosis (SSc) is associated with a poor prognosis.
- Conduction defects and arrhythmias are common in SSc patients, increasing the risk of sudden cardiac death.
Purpose of the Study:
- To evaluate the efficacy of electrophysiologic studies and implantable cardioverter-defibrillators (ICDs) in managing ventricular arrhythmias in SSc patients.
- To determine if ICD implantation can prevent sudden cardiac death in this high-risk population.
Main Methods:
- Implantable cardioverter-defibrillators (ICDs) were implanted in 10 patients diagnosed with systemic sclerosis (SSc) and confirmed cardiac involvement.
- Device data was analyzed over a 36-month follow-up period.
Main Results:
- Three out of 10 patients experienced episodes of ventricular tachycardia during the follow-up period.
- The implanted ICDs successfully detected and reverted these episodes of ventricular tachycardia via electrical shock delivery.
Conclusions:
- Implantation of an implantable cardioverter-defibrillator (ICD) may be a recommended intervention for patients with systemic sclerosis (SSc) presenting with ventricular arrhythmias.
- ICDs demonstrate potential in preventing sudden cardiac death in SSc patients with significant cardiac involvement and arrhythmias.
Objective:
Cardiac involvement means a poor prognosis in systemic sclerosis (SSc). Conduction defects and arrhythmias are frequent in patients with SSc, and may result in sudden cardiac death. We tested whether electrophysiologic studies and implantation of cardioverter defibrillators are recommended when ventricular arrhythmias are present.
Method:
A cardioverter defibrillator was implanted in 10 patients with SSc who had heart involvement.
Result:
After 36 months, analysis of the device showed several episodes of ventricular tachycardia in 3 patients, which were promptly reverted by electrical shock delivery.
Conclusion:
In patients with SSc who are affected by ventricular arrhythmias, the implantation of a cardioverter defibrillator may prevent sudden cardiac death.
More Related Videos
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy VI: Nursing Management
Cardiopulmonary Resuscitation III: AED Use